Sacroiliac Joint Fusion Market Size, Share & Trends Analysis Report By Indication (Degenerative Sacroiliitis, Sacral Disruption), By Treatment Type (Surgery, Injections), By End-user, By Region, And Segment Forecasts, 2024 - 2030
Sacroiliac Joint Fusion Market Growth & Trends
The global sacroiliac joint fusion market size is expected to reach USD 2.49 billion by 2030, according to a new report by Grand View Research, Inc.It is expected to expand at a CAGR of 19.8% from 2024 to 2030. Key market players are investing substantially in Research & Development (R&D) activities to create innovative and effective devices. This increase in R&D activities is expected to drive market growth over the coming years. In addition, the market is expected to grow further due to the increasing prevalence of bone disorders and ongoing technological advancements.
Increasing prevalence of lower back, buttock, groin, and lower extremity pain drives SI joint fusion market growth. These chronic and debilitating forms of pain have become alarmingly common, affecting a substantial portion of the global population. This trend poses significant challenges to healthcare systems and fuels demand for innovative solutions to alleviate suffering and restore mobility. Chronic pain in the lower back, buttock, groin, and lower extremity represents a significant portion of SI joint disorder cases, comprising 10% to 26% of such cases, as the Centers for Medicare & Medicaid Services reported in December 2021. The prevalence of symptoms associated with SI joint disorders highlights their substantial healthcare challenge.
In addition, a factor propelling market growth is the increasing use of innovative materials and technologies to develop improved and safer SI joint fusion systems. For instance, in October 2022, Aurora Spine, a company specializing in regenerative technologies focusing on minimally invasive approaches, announced that it had received 510(k) clearance from the U.S. FDA for its patented SiLO TFX MIS. The SI joint fixation system is a minimally invasive solution intended for SI joint fusion in cases involving SI joint disruptions and degenerative sacroiliitis. The SiLO TFX system comprises an ilium screw, sacrum screw, associated instrumentation, and transfixing cone designed to achieve fixation and stability for bony fusion between the sacrum and ilium. Thus, such technological advancements are expected to boost market growth.
North America dominated the market with the largest revenue share in 2023. North America is the leading market for upper limb prosthetics across the globe. The dominance can be attributed to advanced healthcare infrastructure, the presence of key companies, and growing reimbursement coverage. Key market players are involved in implementing strategic initiatives, such as conducting clinical tests of their products, regional expansion, patent applications, product launches, and partnerships & collaborations to increase their market share.
Sacroiliac Joint Fusion Market Report Highlights
By indication, the degenerative sacroiliitis segment accounted for the largest revenue share of 38.6% in 2023. Growing awareness about the condition and improving diagnostic capabilities for sacroiliac joint disorders are among the major factors that drive the growth of the segment.
By treatment type, surgery segment dominated the market in terms of revenue share in 2023. Its dominance is attributed to the growing preference for minimally invasive surgeries, driven by their advantages, including smaller incisions, decreased pain & scarring, and quicker recovery periods.
By end user, the hospitals segment dominated the market in 2023. Hospitals offer specialized, extended care for patients, and their treatments are frequently eligible for reimbursement, further fostering their adoption.
North America dominated the market with the largest revenue share in 2023 owing to well-established healthcare infrastructure and increasing R&D investments by companies.
Asia Pacific region is expected to grow at the fastest rate during the forecast period, owing to the presence of a large patient pool, developing healthcare facilities, and investments by key companies in this region.
Please note The report will be delivered in 2-3 business days upon order notification.
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Treatment
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America